IBDEI1CY ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24056,1,2,0)
 ;;=2^99315
 ;;^UTILITY(U,$J,358.3,24057,0)
 ;;=99316^^132^1467^2
 ;;^UTILITY(U,$J,358.3,24057,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24057,1,1,0)
 ;;=1^NH DISCHARGE DAY MGMT > 30MIN
 ;;^UTILITY(U,$J,358.3,24057,1,2,0)
 ;;=2^99316
 ;;^UTILITY(U,$J,358.3,24058,0)
 ;;=188.9^^133^1468^6
 ;;^UTILITY(U,$J,358.3,24058,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24058,1,1,0)
 ;;=1^188.9
 ;;^UTILITY(U,$J,358.3,24058,1,2,0)
 ;;=2^BLADDER CANCER,UNSPEC
 ;;^UTILITY(U,$J,358.3,24058,2)
 ;;=^267253
 ;;^UTILITY(U,$J,358.3,24059,0)
 ;;=162.9^^133^1468^27
 ;;^UTILITY(U,$J,358.3,24059,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24059,1,1,0)
 ;;=1^162.9
 ;;^UTILITY(U,$J,358.3,24059,1,2,0)
 ;;=2^LUNG CANCER
 ;;^UTILITY(U,$J,358.3,24059,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,24060,0)
 ;;=191.9^^133^1468^8
 ;;^UTILITY(U,$J,358.3,24060,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24060,1,1,0)
 ;;=1^191.9
 ;;^UTILITY(U,$J,358.3,24060,1,2,0)
 ;;=2^BRAIN CANCER,UNSPEC
 ;;^UTILITY(U,$J,358.3,24060,2)
 ;;=^267279
 ;;^UTILITY(U,$J,358.3,24061,0)
 ;;=171.9^^133^1468^15
 ;;^UTILITY(U,$J,358.3,24061,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24061,1,1,0)
 ;;=1^171.9
 ;;^UTILITY(U,$J,358.3,24061,1,2,0)
 ;;=2^CONNECTIVE/OTH SOFT TISSUE CANCER,SITE UNSPEC
 ;;^UTILITY(U,$J,358.3,24061,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,24062,0)
 ;;=150.9^^133^1468^17
 ;;^UTILITY(U,$J,358.3,24062,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24062,1,1,0)
 ;;=1^150.9
 ;;^UTILITY(U,$J,358.3,24062,1,2,0)
 ;;=2^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,24062,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,24063,0)
 ;;=153.9^^133^1468^14
 ;;^UTILITY(U,$J,358.3,24063,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24063,1,1,0)
 ;;=1^153.9
 ;;^UTILITY(U,$J,358.3,24063,1,2,0)
 ;;=2^COLON CANCER
 ;;^UTILITY(U,$J,358.3,24063,2)
 ;;=^267078
 ;;^UTILITY(U,$J,358.3,24064,0)
 ;;=152.9^^133^1468^59
 ;;^UTILITY(U,$J,358.3,24064,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24064,1,1,0)
 ;;=1^152.9
 ;;^UTILITY(U,$J,358.3,24064,1,2,0)
 ;;=2^SMALL INTESTINE CANCER
 ;;^UTILITY(U,$J,358.3,24064,2)
 ;;=^267077
 ;;^UTILITY(U,$J,358.3,24065,0)
 ;;=193.^^133^1468^63
 ;;^UTILITY(U,$J,358.3,24065,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24065,1,1,0)
 ;;=1^193.
 ;;^UTILITY(U,$J,358.3,24065,1,2,0)
 ;;=2^THYROID CANCER
 ;;^UTILITY(U,$J,358.3,24065,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,24066,0)
 ;;=284.9^^133^1468^4
 ;;^UTILITY(U,$J,358.3,24066,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24066,1,1,0)
 ;;=1^284.9
 ;;^UTILITY(U,$J,358.3,24066,1,2,0)
 ;;=2^APLASTIC ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,24066,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,24067,0)
 ;;=170.9^^133^1468^7
 ;;^UTILITY(U,$J,358.3,24067,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24067,1,1,0)
 ;;=1^170.9
 ;;^UTILITY(U,$J,358.3,24067,1,2,0)
 ;;=2^BONE AND CARTILAGE CANCER,SITE UNSPEC
 ;;^UTILITY(U,$J,358.3,24067,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,24068,0)
 ;;=175.9^^133^1468^10
 ;;^UTILITY(U,$J,358.3,24068,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24068,1,1,0)
 ;;=1^175.9
 ;;^UTILITY(U,$J,358.3,24068,1,2,0)
 ;;=2^BREAST CANCER-MALE,UNSPEC
 ;;^UTILITY(U,$J,358.3,24068,2)
 ;;=^267205
 ;;^UTILITY(U,$J,358.3,24069,0)
 ;;=209.10^^133^1468^37
 ;;^UTILITY(U,$J,358.3,24069,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24069,1,1,0)
 ;;=1^209.10
 ;;^UTILITY(U,$J,358.3,24069,1,2,0)
 ;;=2^MALIG CARCINOID, LARGE INTESTINE
 ;;^UTILITY(U,$J,358.3,24069,2)
 ;;=^336722
 ;;^UTILITY(U,$J,358.3,24070,0)
 ;;=209.29^^133^1468^38
 ;;^UTILITY(U,$J,358.3,24070,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24070,1,1,0)
 ;;=1^209.29
 ;;
 ;;$END ROU IBDEI1CY
